A Potentially Misleading Name: <i>Staphylococcus argenteus</i> in an Urosepsis: A Case Report
<i>Staphylococcus argenteus</i>, a recently recognized species within the <i>Staphylococcus aureus complex</i>, shares numerous virulence traits with <i>S. aureus</i>. While <i>S. argenteus</i> typically lacks pigmentation and exhibits greater antibiotic susceptibility compared to <i>S. aureus</i>, it can cause severe infections, including bacteremia. Clinicians can be misled by its name and may not give it the necessary attention. It may also be misidentified as a <i>S. aureus</i> by the microbiology lab. We present the case of a 56-year-old man with a complex medical history who developed a polymicrobial urosepsis involving <i>S. argenteus</i>. It was initially misinterpreted as a contaminant in urinary samples by an external laboratory. The patient subsequently developed septic shock and was admitted to intensive care unit. The blood cultures confirmed <i>S. argenteus</i> associated with <i>E. coli</i> and <i>K. pneumoniae</i> bacteremia. He was successfully treated with high-dose intravenous floxacillin and oral ciprofloxacin. Whole-genome sequencing confirmed the isolate as <i>S. argenteus</i> (ST2250). This case underscores the diagnostic and clinical challenges posed by <i>S. argenteus</i>, particularly in regions where its prevalence is low. <i>S. argenteus</i> harbors the majority of <i>S. aureus</i> virulence genes and causes a comparable spectrum of disease. Epidemiological data indicate regional differences in its prevalence and clinical impact. Some studies report lower virulence while others suggest worse outcomes. The case illustrates the importance of accurate identification using techniques like MALDI-TOF MS and whole-genome sequencing. Clinicians and microbiologists should remain vigilant and consider <i>S. argenteus</i> as a pathogen, warranting appropriate antimicrobial therapy and clinical attention. Differentiating it from <i>S. aureus</i> might be relevant for guiding therapy, surveillance, and infection control, particularly given emerging reports of methicillin-resistant <i>S. argenteus</i> strains.
Authors
- Nicolas Yin (ORCID: https://orcid.org/0000-0003-1706-6869)
- Philippe Clevenbergh (ORCID: https://orcid.org/0000-0002-0522-9686)
- Bhavna Mahadeb (ORCID: https://orcid.org/0000-0002-9469-4132)
- Evelyne Maillart (ORCID: https://orcid.org/0000-0002-5354-068X)
- Mariana Dumitru
- Y Hasnaoui
- M T Talpos
Institutions
- Centre Hospitalier Universitaire Brugmann (BE)
- Boston University Brussels (BE)
Publication Details
- Journal
- Case Reports in Infectious Diseases
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/crdi/2880273
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00